Research Article
Serum Levels of Resistin, Adiponectin, and Apelin in Gastroesophageal Cancer Patients
Table 4
Relationship between clinic-pathological parameters and serum levels of resistin, adiponectin, and apelin in GEC patients.
| | | Resistin (ng/mL) | Adiponectin (g/mL) | Apelin (pg/mL) | | mean ± SD | | mean ± SD | | mean ± SD | |
| | Histological type | | 0.495 | | 0.277 | | 0.065 | | scc () | 10.9 ± 3.3 | | 9.02 ± 4.33 | | 886 ± 127 | | | adca () | 10.4 ± 3.4 | | 8.08 ± 3.59 | | 836 ± 118 | | | TNM stage | | 0.223 | | 0.260 | | 0.381 | | II () | 9.2 ± 3.3 | | 9.3 ± 3.8 | | 889 ± 117 | | | III () | 10.7 ± 2.7 | | 7.9 ± 4.8 | | 818 ± 176 | | | IV () | 11.2 ± 3.6 | | 7.2 ± 2.5 | | 862 ± 199 | | | Tumor stage (T) | | 0.330 | | 0.484 | | 0.231 | | T2 () | 9.1 ± 3.3 | | 8.8 ± 3.7 | | 801 ± 135 | | | T3 () | 9.9 ± 3.6 | | 8.3 ± 6.4 | | 828 ± 160 | | | T4 () | 11.1 ± 3.2 | | 7.4 ± 1.2 | | 891 ± 154 | | | Lymph node metastasis | | 0.142 | | 0.012* | | 0.104 | | N0 () | 10.2 ± 2.9 | | 9.5 ± 3.7 | | 821 ± 146 | | | N1 () | 11.3 ± 3.7 | | 7.4 ± 3.8 | | 865 ± 101 | | | Distant metastasis | | <0.001* | | 0.037* | | 0.106 | | M0 () | 9.6 ± 3.1 | | 9.5 ± 4.1 | | 836 ± 152 | | | M1 () | 12.2 ± 3.2 | | 7.7 ± 3.6 | | 881 ± 101 | |
|
|
Data analyzed using one-way ANOVA or -test for independent samples. scc: squamous cell carcinoma; adca: adenocarcinoma; statistically significant.
|
